Chitinase 3‐like 1 deficiency ameliorates liver fibrosis by promoting hepatic macrophage apoptosis
暂无分享,去创建一个
K. Tomita | J. Yamamoto | S. Miura | S. Seki | R. Hokari | C. Kurihara | Y. Okada | C. Watanabe | S. Komoto | M. Nishikawa | H. Furuhashi | N. Shibuya | H. Hozumi | M. Higashiyama | H. Nakashima | N. Sugihara | S. Nishii | Kenichi Inaba | Akinori Wada | Akinori Mizoguchi | Kazuki Horiuchi | Yoshinori Hanawa | Hirotaka Furuhashi | Masaaki Higashiyama
[1] S. Weinman,et al. Regulation of Hepatic Inflammation via Macrophage Cell Death , 2018, Seminars in Liver Disease.
[2] G. Pera,et al. High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population‐Based Study , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[3] T. Hibi,et al. Aortic carboxypeptidase–like protein, a WNT ligand, exacerbates nonalcoholic steatohepatitis , 2018, The Journal of clinical investigation.
[4] K. Tomita,et al. Vitamin A‐coupled liposome system targeting free cholesterol accumulation in hepatic stellate cells offers a beneficial therapeutic strategy for liver fibrosis , 2018, Hepatology research : the official journal of the Japan Society of Hepatology.
[5] J. Jia,et al. Changes in serum chitinase 3‐like 1 levels correlate with changes in liver fibrosis measured by two established quantitative methods in chronic hepatitis B patients following antiviral therapy , 2018, Hepatology research : the official journal of the Japan Society of Hepatology.
[6] T. Wynn,et al. Mechanisms of Organ Injury and Repair by Macrophages. , 2017, Annual review of physiology.
[7] N. Méndez-Sánchez,et al. Management strategies for liver fibrosis. , 2017, Annals of hepatology.
[8] M. Linton,et al. Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis. , 2016, Circulation journal : official journal of the Japanese Circulation Society.
[9] K. Chayama,et al. Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease , 2016, Scientific Reports.
[10] H. Perlman,et al. The inflammatory role of phagocyte apoptotic pathways in rheumatic diseases , 2016, Nature Reviews Rheumatology.
[11] F. Tacke,et al. Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis , 2016, Front. Pharmacol..
[12] E. Seki,et al. TNFα in Liver Fibrosis , 2015, Current Pathobiology Reports.
[13] A. Horuzsko,et al. Kupffer Cell Metabolism and Function. , 2015, Journal of enzymology and metabolism.
[14] A. Orekhov,et al. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis , 2014, Front. Physiol..
[15] T. Hibi,et al. Free cholesterol accumulation in hepatic stellate cells: Mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice , 2014, Hepatology.
[16] Albert Tran,et al. M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease , 2014, Hepatology.
[17] T. Hibi,et al. C‐C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice , 2013, Hepatology.
[18] R. Kaufman,et al. C/EBP Homologous Protein-induced Macrophage Apoptosis Protects Mice from Steatohepatitis* , 2013, The Journal of Biological Chemistry.
[19] T. Hibi,et al. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells. , 2012, Gastroenterology.
[20] C. Liu,et al. Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats , 2010, Laboratory Investigation.
[21] Y. Ngo,et al. Open Access Research Article Prevalence of Liver Fibrosis and Risk Factors in a General Population Using Non-invasive Biomarkers (fibrotest) , 2022 .
[22] R. Flavell,et al. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosis , 2009, The Journal of experimental medicine.
[23] R. Fontana,et al. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C , 2008, Hepatology.
[24] T. Hibi,et al. Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice , 2005, Gut.
[25] S. Forbes,et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. , 2005, The Journal of clinical investigation.
[26] L. Skovgaard,et al. Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. , 2003, Journal of hepatology.
[27] H. Perlman,et al. Constitutively Activated Akt-1 Is Vital for the Survival of Human Monocyte-Differentiated Macrophages , 2001, The Journal of experimental medicine.
[28] J. Henriksen,et al. Serum YKL-40 is increased in patients with hepatic fibrosis. , 2000, Journal of hepatology.
[29] A. B. Sukhomlinov,et al. [Liver cirrhosis]. , 1989, Fel'dsher i akusherka.